113 related articles for article (PubMed ID: 28609651)
1. From One to Many: Further Refinement of Medulloblastoma Subtypes Offers Promise for Personalized Therapy.
Bavle A; Parsons DW
Cancer Cell; 2017 Jun; 31(6):727-729. PubMed ID: 28609651
[TBL] [Abstract][Full Text] [Related]
2. Intertumoral Heterogeneity within Medulloblastoma Subgroups.
Cavalli FMG; Remke M; Rampasek L; Peacock J; Shih DJH; Luu B; Garzia L; Torchia J; Nor C; Morrissy AS; Agnihotri S; Thompson YY; Kuzan-Fischer CM; Farooq H; Isaev K; Daniels C; Cho BK; Kim SK; Wang KC; Lee JY; Grajkowska WA; Perek-Polnik M; Vasiljevic A; Faure-Conter C; Jouvet A; Giannini C; Nageswara Rao AA; Li KKW; Ng HK; Eberhart CG; Pollack IF; Hamilton RL; Gillespie GY; Olson JM; Leary S; Weiss WA; Lach B; Chambless LB; Thompson RC; Cooper MK; Vibhakar R; Hauser P; van Veelen MC; Kros JM; French PJ; Ra YS; Kumabe T; López-Aguilar E; Zitterbart K; Sterba J; Finocchiaro G; Massimino M; Van Meir EG; Osuka S; Shofuda T; Klekner A; Zollo M; Leonard JR; Rubin JB; Jabado N; Albrecht S; Mora J; Van Meter TE; Jung S; Moore AS; Hallahan AR; Chan JA; Tirapelli DPC; Carlotti CG; Fouladi M; Pimentel J; Faria CC; Saad AG; Massimi L; Liau LM; Wheeler H; Nakamura H; Elbabaa SK; Perezpeña-Diazconti M; Chico Ponce de León F; Robinson S; Zapotocky M; Lassaletta A; Huang A; Hawkins CE; Tabori U; Bouffet E; Bartels U; Dirks PB; Rutka JT; Bader GD; Reimand J; Goldenberg A; Ramaswamy V; Taylor MD
Cancer Cell; 2017 Jun; 31(6):737-754.e6. PubMed ID: 28609654
[TBL] [Abstract][Full Text] [Related]
3. Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development.
Williamson D; Schwalbe EC; Hicks D; Aldinger KA; Lindsey JC; Crosier S; Richardson S; Goddard J; Hill RM; Castle J; Grabovska Y; Hacking J; Pizer B; Wharton SB; Jacques TS; Joshi A; Bailey S; Clifford SC
Cell Rep; 2022 Aug; 40(5):111162. PubMed ID: 35926460
[TBL] [Abstract][Full Text] [Related]
4. Medulloblastoma epigenetics and the path to clinical innovation.
Haltom AR; Toll SA; Cheng D; Maegawa S; Gopalakrishnan V; Khatua S
J Neurooncol; 2020 Oct; 150(1):35-46. PubMed ID: 32816225
[TBL] [Abstract][Full Text] [Related]
5. DNA-methylation profiling discloses significant advantages over NanoString method for molecular classification of medulloblastoma.
Korshunov A; Chavez L; Northcott PA; Sharma T; Ryzhova M; Jones DTW; von Deimling A; Pfister SM; Kool M
Acta Neuropathol; 2017 Dec; 134(6):965-967. PubMed ID: 29027579
[No Abstract] [Full Text] [Related]
6. Intertumoral and intratumoral heterogeneity as a barrier for effective treatment of medulloblastoma.
Wang X; Ramaswamy V; Remke M; Mack SC; Dubuc AM; Northcott PA; Taylor MD
Neurosurgery; 2013 Aug; 60 Suppl 1():57-63. PubMed ID: 23839353
[No Abstract] [Full Text] [Related]
7. Differential Expression of Genes for Ubiquitin Ligases in Medulloblastoma Subtypes.
Vriend J; Tate RB
Cerebellum; 2019 Jun; 18(3):469-488. PubMed ID: 30810905
[TBL] [Abstract][Full Text] [Related]
8. Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays.
Hovestadt V; Remke M; Kool M; Pietsch T; Northcott PA; Fischer R; Cavalli FM; Ramaswamy V; Zapatka M; Reifenberger G; Rutkowski S; Schick M; Bewerunge-Hudler M; Korshunov A; Lichter P; Taylor MD; Pfister SM; Jones DT
Acta Neuropathol; 2013 Jun; 125(6):913-6. PubMed ID: 23670100
[No Abstract] [Full Text] [Related]
9. Subgroup-specific roles of primary cilia in medulloblastoma.
Marino S
Genes Dev; 2022 Jun; 36(11-12):650-651. PubMed ID: 35835507
[TBL] [Abstract][Full Text] [Related]
10. Redefining the molecular substructure of medulloblastoma.
Benmaamar R
Lancet Oncol; 2017 Sep; 18(9):e514. PubMed ID: 28757377
[No Abstract] [Full Text] [Related]
11. Intercellular heterogeneity of expression of the MGMT DNA repair gene in pediatric medulloblastoma.
Rood BR; Zhang H; Cogen PH
Neuro Oncol; 2004 Jul; 6(3):200-7. PubMed ID: 15279712
[TBL] [Abstract][Full Text] [Related]
12. Gene expression analyses of the spatio-temporal relationships of human medulloblastoma subgroups during early human neurogenesis.
Hooper CM; Hawes SM; Kees UR; Gottardo NG; Dallas PB
PLoS One; 2014; 9(11):e112909. PubMed ID: 25412507
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma.
Lindsey JC; Lusher ME; Anderton JA; Gilbertson RJ; Ellison DW; Clifford SC
Br J Cancer; 2007 Jul; 97(2):267-74. PubMed ID: 17579622
[TBL] [Abstract][Full Text] [Related]
14. [Risk stratification in medulloblastoma: screening for molecular markers].
Ebinger M; Senf L; Scheurlen W
Klin Padiatr; 2006; 218(3):139-42. PubMed ID: 16688669
[TBL] [Abstract][Full Text] [Related]
15. A molecular fingerprint for medulloblastoma.
Lee Y; Miller HL; Jensen P; Hernan R; Connelly M; Wetmore C; Zindy F; Roussel MF; Curran T; Gilbertson RJ; McKinnon PJ
Cancer Res; 2003 Sep; 63(17):5428-37. PubMed ID: 14500378
[TBL] [Abstract][Full Text] [Related]
16. Exploratory analysis of ERCC2 DNA methylation in survival among pediatric medulloblastoma patients.
Banfield E; Brown AL; Peckham EC; Rednam SP; Murray J; Okcu MF; Mitchell LE; Chintagumpala MM; Lau CC; Scheurer ME; Lupo PJ
Cancer Epidemiol; 2016 Oct; 44():161-166. PubMed ID: 27607585
[TBL] [Abstract][Full Text] [Related]
17. Multiplex meta-analysis of medulloblastoma expression studies with external controls.
Morgan AA; Achrol AS; Li MD; Khatri PJ; Cheshier SH
Pac Symp Biocomput; 2014; ():99-109. PubMed ID: 24297537
[TBL] [Abstract][Full Text] [Related]
18. DNA-methylation subgroups carry no prognostic significance in ATRT-SHH patients in clinical trial cohorts.
Tran QT; Upadhyaya SA; Billups CA; Onar-Thomas A; Alom MZ; Carey SS; Robinson GW; Ellison DW; Gajjar A; Orr BA
Acta Neuropathol; 2023 Sep; 146(3):543-545. PubMed ID: 37522896
[No Abstract] [Full Text] [Related]
19. Next-Generation Profiling of Medulloblastoma: Old Drugs Are an Elegant Weapon in a Civilized Age.
Nör C; Ramaswamy V
Cancer Res; 2021 Jan; 81(2):264-265. PubMed ID: 33452214
[TBL] [Abstract][Full Text] [Related]
20. Array-based profiling of reference-independent methylation status (aPRIMES) identifies frequent promoter methylation and consecutive downregulation of ZIC2 in pediatric medulloblastoma.
Pfister S; Schlaeger C; Mendrzyk F; Wittmann A; Benner A; Kulozik A; Scheurlen W; Radlwimmer B; Lichter P
Nucleic Acids Res; 2007; 35(7):e51. PubMed ID: 17344319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
